{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:21:36Z","timestamp":1791598896733,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jcin.2025.06.022","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T18:28:55Z","timestamp":1754936935000},"page":"1833-1847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Renal Denervation in Hypertension and Chronic Heart Failure"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-9556","authenticated-orcid":false,"given":"Lucas","family":"Lauder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-1441","authenticated-orcid":false,"given":"Naomi D.L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otmar","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2025.06.022_bib1","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib2","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcin.2025.06.022_bib3","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/HYP.0000000000000240","article-title":"Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association","volume":"81","author":"Cluett","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib4","article-title":"SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations","volume":"2","author":"Swaminathan","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jcin.2025.06.022_bib5","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","article-title":"Hypertension management in patients with cardiovascular comorbidities","volume":"44","author":"Lauder","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.amepre.2024.07.005","article-title":"Health care expenditures and use associated with hypertension among U.S. adults","volume":"67","author":"Wang","year":"2024","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","article-title":"Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories","volume":"52","author":"Blaschke","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jcin.2025.06.022_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2021.02.016","article-title":"Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: a population-based retrospective study on 100785 patients","volume":"330","author":"Scalvini","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib13","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehy377","article-title":"Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-Adherence Academic Research Consortium (NARC)","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2011.05.028","article-title":"Trouble getting started: predictors of primary medication nonadherence","volume":"124","author":"Fischer","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2025.06.022_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcin.2025.06.022_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.116.07464","article-title":"Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension","volume":"68","author":"Berra","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib18","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2666-7568(21)00281-6","article-title":"The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care","volume":"3","author":"Herrett","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jcin.2025.06.022_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/jech.2007.068817","article-title":"Co-occurrence of risk factors for cardiovascular disease by social class: 1958 British birth cohort","volume":"62","author":"Power","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jcin.2025.06.022_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jcin.2025.06.022_bib21","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3390\/cells11193157","article-title":"Left atrial myocardium in arterial hypertension","volume":"11","author":"Kockskamper","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcin.2025.06.022_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.amjcard.2011.05.037","article-title":"Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up","volume":"108","author":"Krishnamoorthy","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib23","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","article-title":"Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system","volume":"72","author":"Sharp","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2025.06.022_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/japplphysiol.00832.2009","article-title":"The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management","volume":"108","author":"Esler","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jcin.2025.06.022_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4244\/EIJ-D-23-00264","article-title":"Histological examination of renal nerve distribution, density, and function in humans","volume":"19","author":"Struthoff","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.120.15106","article-title":"Microdissection of the human renal nervous system: implications for performing renal denervation procedures","volume":"76","author":"Garcia-Touchard","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.HYP.0000047205.52509.8A","article-title":"Neural control of the kidney: past, present, and future","volume":"41","author":"DiBona","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","article-title":"Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat","volume":"26","author":"Campese","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2025.06.022_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11906-002-0038-x","article-title":"Renal afferents and hypertension","volume":"4","author":"Ciriello","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jcin.2025.06.022_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-031620-093431","article-title":"Renal denervation to treat heart failure","volume":"83","author":"Sharp","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1838(83)90112-1","article-title":"Assessment of possible parasympathetic innervation of the kidney","volume":"8","author":"Norvell","year":"1983","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.jcin.2025.06.022_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aanat.2015.11.004","article-title":"The morphological substrate for Renal Denervation: Nerve distribution patterns and parasympathetic nerves. A post-mortem histological study","volume":"204","author":"van Amsterdam","year":"2016","journal-title":"Ann Anat"},{"key":"10.1016\/j.jcin.2025.06.022_bib34","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1681\/ASN.2021111518","article-title":"Anatomical evidence for parasympathetic innervation of the renal vasculature and pelvis","volume":"33","author":"Cheng","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcin.2025.06.022_bib35","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1152\/ajpregu.00647.2009","article-title":"Translational medicine: the antihypertensive effect of renal denervation","volume":"298","author":"DiBona","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.06.022_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0002-9149(84)80208-8","article-title":"Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure","volume":"54","author":"Swedberg","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/oxfordjournals.eurheartj.a062577","article-title":"Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium","volume":"9","author":"B\u00f6hm","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.78.1.41","article-title":"In vivo measurement of neuronal uptake of norepinephrine in the human heart","volume":"78","author":"Goldstein","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.06.022_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","article-title":"Evidence for reduction of norepinephrine uptake sites in the failing human heart","volume":"25","author":"B\u00f6hm","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0735-1097(90)90544-Y","article-title":"Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings","volume":"16","author":"Ferguson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-8703(87)90318-8","article-title":"Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration","volume":"114","author":"Rector","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib44","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1001\/archinte.163.22.2696","article-title":"Role of the natriuretic peptide system in cardiorenal protection","volume":"163","author":"McFarlane","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.06.022_bib46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.25.6.1252","article-title":"Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats","volume":"25","author":"Kim","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib47","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney","volume":"70","author":"Polhemus","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib48","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1161\/HYPERTENSIONAHA.122.20756","article-title":"Efficacy of antihypertensive drugs of different classes after renal denervation in spontaneously hypertensive rats","volume":"80","author":"Hohl","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.122.20503","article-title":"Effects of renal denervation on sympathetic nerve traffic and correlates in drug-resistant and uncontrolled hypertension: a systematic review and meta-analysis","volume":"80","author":"Biffi","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib50","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jacc.2021.04.044","article-title":"Changes in plasma renin activity after renal artery sympathetic denervation","volume":"77","author":"Mahfoud","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib51","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.1953.03690160001001","article-title":"Splanchnicectomy for essential hypertension; results in 1,266 cases","volume":"152","author":"Smithwick","year":"1953","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2025.06.022_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4244\/EIJV10I2A46","article-title":"Evaluation of lesion and thermodynamic characteristics of Symplicity and EnligHTN renal denervation systems in a phantom renal artery model","volume":"10","author":"Al Raisi","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4244\/EIJV11I4A96","article-title":"Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity","volume":"11","author":"Pathak","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3236","article-title":"Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension","volume":"7","author":"Tzafriri","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carrev.2015.04.008","article-title":"Next generation renal denervation: chemical \u201cperivascular\u201d renal denervation with alcohol using a novel drug infusion catheter","volume":"16","author":"Fischell","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jcin.2025.06.022_bib56","first-page":"1227","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"18","author":"Barbato","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib57","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.124.069709","article-title":"Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis","volume":"150","author":"Vukadinovic","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.06.022_bib58","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2025.06.022_bib60","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib61","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.124.069215","article-title":"Efficacy and safety of catheter-based radiofrequency renal denervation in Chinese patients with uncontrolled hypertension: the randomized, sham-controlled, multi-center Iberis-HTN trial","volume":"150","author":"Jiang","year":"2024","journal-title":"Circulation"},{"issue":"44","key":"10.1016\/j.jcin.2025.06.022_bib62","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1093\/eurheartj\/ehae703","article-title":"The Netrod\u2122 six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial","volume":"45","author":"Li","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib63","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications","volume":"82","author":"Kandzari","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101606","article-title":"Long-term, patient-level analysis of radiofrequency renal denervation in the SYMPLICITY clinical trial program","volume":"4","author":"Mahfoud","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jcin.2025.06.022_bib65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","article-title":"Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 trial","volume":"400","author":"Bhatt","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib66","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib67","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.4244\/EIJ-D-22-00305","article-title":"Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial","volume":"18","author":"Rader","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib68","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1161\/HYPERTENSIONAHA.123.22314","article-title":"Long-term blood pressure reductions following catheter-based renal denervation: a systematic review and meta-analysis","volume":"81","author":"Sesa-Ashton","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jcin.2025.06.022_bib69","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcin.2008.03.013","article-title":"Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007","volume":"1","author":"Applegate","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.06.022_bib70","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ndt\/gfab154","article-title":"Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY registry with follow-up data of 3 years","volume":"37","author":"Ott","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcin.2025.06.022_bib71","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/HJH.0000000000001798","article-title":"Regression of organ damage following renal denervation in resistant hypertension: a meta-analysis","volume":"36","author":"Kordalis","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcin.2025.06.022_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14017431.2022.2060526","article-title":"Renal denervation in patients who do not respond to cardiac resynchronization therapy","volume":"56","author":"Pietila-Effati","year":"2022","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.jcin.2025.06.022_bib74","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ejhf.502","article-title":"Renal Denervation in Heart Failure With Preserved Ejection Fraction (RDT-PEF): a randomized controlled trial","volume":"18","author":"Patel","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcin.2025.06.022_bib75","article-title":"Renal sympathetic denervation in patients with heart failure with preserved ejection fraction","volume":"14","author":"Kresoja","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcin.2025.06.022_bib76","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcin.2025.06.022_bib77","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2025.06.022_bib78","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib79","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jacc.2022.08.802","article-title":"Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range","volume":"80","author":"Mahfoud","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2025.06.022_bib80","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","article-title":"The sympathetic nervous system and the metabolic syndrome","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcin.2025.06.022_bib81","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jcin.2025.06.022_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0043-57237","article-title":"Hepatic innervations and nonalcoholic fatty liver disease","volume":"43","author":"Adori","year":"2023","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcin.2025.06.022_bib83","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41598-022-05475-6","article-title":"Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation","volume":"12","author":"Tzafriri","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcin.2025.06.022_bib84","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41440-023-01287-x","article-title":"Multi-organ denervation: a novel approach to combat cardiometabolic disease","volume":"46","author":"Kiuchi","year":"2023","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jcin.2025.06.022_bib85","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.4244\/EIJ-D-23-00836","article-title":"Renal denervation in the management of hypertension","volume":"20","author":"Lauder","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2025.06.022_bib86","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2025.06.022_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102626","article-title":"Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial","volume":"72","author":"Wang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jcin.2025.06.022_bib88","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","article-title":"Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial","volume":"149","author":"Kandzari","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2025.06.022_bib89","first-page":"E153","article-title":"Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: a prospective, randomized, controlled, pilot study","volume":"89","author":"Chen","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.06.022_bib90","first-page":"644","article-title":"Renal denervation in patients with heart failure secondary to Chagas\u2019 disease: a pilot randomized controlled trial","volume":"94","author":"Spadaro","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2025.06.022_bib91","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5603\/CJ.a2018.0028","article-title":"Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial","volume":"26","author":"Gao","year":"2019","journal-title":"Cardiol J"},{"key":"10.1016\/j.jcin.2025.06.022_bib92","first-page":"240","article-title":"Renal denervation in patients with symptomatic chronic heart failure despite resynchronization therapy\u2014a pilot study","volume":"15","author":"Drozdz","year":"2019","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"10.1016\/j.jcin.2025.06.022_bib93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12471-021-01633-z","article-title":"Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study","volume":"30","author":"Feyz","year":"2022","journal-title":"Neth Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825017327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825017327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:11Z","timestamp":1786422011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825017327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":93,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1936879825017327"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.06.022","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Denervation in Hypertension and Chronic Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}